My tribute to my dad, who passed away last month in the UK.
He was a proud Indian immigrant *and* a proud British citizen.
His life story is one long rebuttal to the nativists, bigots and xenophobes.
Watch. To. The. End.
#SVIN2025 just casually dropped a bombshell:
CREST-2 says carotid stenting > CEA + medical management.
Yes, you read that right.
The data has spoken: ARD 3.2%, RR 2.13, and the p-value didn’t come to play.
The plenary hall was purely electric.
You could feel the field shift in real time.
🚨 Basilar stroke with life-saving thrombectomy!
LKW 4 hrs
Trevo stent retriever captured large plaque burden — achieved TICI 3 reperfusion 🧠💥
Patient recovered with only mild right arm weakness.
Time is brain — and flow is life! 💪
#Stroke#NeuroEndovascularSurgery#SVIN
Bottom line: do not withhold TNK Before EVT if indicated
Intravenous Tenecteplase before Thrombectomy in Stroke | New England Journal of Medicine https://t.co/02BAuWzyVg
Are you ready for the future of neuroendovascular fellowship training?
Join us our upcoming webinar for program directors, faculty, and applicants to gain firsthand insights from the Neuroendovascular Fellowship Match Task Force leaders.
One week left to register, secure your spot here: https://t.co/bPmGAw9LM5
#SVIN #FellowshipMatch
EXTREMELY competitive match day results are in! Huge congrats to those who made the cut! Neurology offers a world of a cutting-edge subspecialties like Headache, Stroke, Pain, Epilepsy, and Neuroendovascular Surgery … where innovation meets precision! #MatchDay@gwneurology
I am pleased to share our recent publication on the use of statins in acute stroke patients who underwent endovascular thrombectomy. My sincere gratitude to the entire team whose dedication and efforts made this work possible @almuftifawaz 🙏.
https://t.co/gzsc8Irv6t
Honored to serve as the Senior Investigator for the recently awarded @svinsociety - Pilot Scientific Grant, supporting our highly anticipated #TRIGEMINAL Trial for Migraine Headaches—(The Targeted Relief in Trigeminovascular Headaches through Middle Meningeal Artery Embolization)!
With over 39 million migraine sufferers in the U.S., our mission is to advance innovative treatments and improve quality of life for these patients.
Thrilled to collaborate with my fellow #ImanMoeini and #World renown headache specialsts as we work toward advancing treatments in this critical area.
#InnovationInNeurology #TRIGEMINALTrial #HeadacheResearch
#Migraine
@RaulNogueiraMD@NguyenThanhMD@AmeerEHassan@PascalJabbourMD Jabbour @DavidAltschulMD@AshuPJadhav@elghanemmoh@AlAlBayati1@TudorGJovin@AlexandraCzap
TENSION large core stroke RCT 12M results: EVT advantage sustained. Quality of life much better after EVT (EQ-5D index score 0.7 vs. 0.4, p = 0.0024). Open access https://t.co/P3R7Zk9Adh @TheLancetNeuro
Are you curious how large core trials will affect your practice?
Should all high NIHSS stroke pts be transferred in?
Is there anyone we shouldn't take?
What is the role of advanced imaging?
Join us on July 1st at 4 PM EST to get answers to those critical questions during the @AANmember Endovascular & Interventional Neurology Section Webinar on "The Large Core Stroke Dilemma."
Register here: https://t.co/YDmj221Mo4
LATE BREAKING @ @svinsociety#SVIN23 by the luminary trailblazer @TudorGJovin
First Presentation of the LASTE trial (in North America).
Prospective multicenter Blinded
randomized Trial
30 CSC
>320pts
1⁰ Outcome for Disability
OR1.63 favoring EVT!
NNT :4.2 (95%CI, 2.8 to 7.8)
Check it out! Legend @TudorGJovin presenting the results of the UNLIMITEDLY large core EVT trial, LASTE, at #SVIN23.
Tx of ASPECTS 0-5 within 7hrs IMPROVES survival and reduces disability!
NNT 4!!!
Congratulations to the Clotbusters for winning the SVIN GAME! It was a very close competition and all teams crushed it! Well done Yasmin Aziz, Aya Ouf, and Azkha Sheikh organizing this fun event! @JZWilleyMD@eytanraz@AlAlBayati1 @AyaOufMD @Azka_ShaikhMD@senyorhomes